Check out this op-ed by Illinois Chamber of Commerce Vice President of Government Affairs Todd Maisch in the Chicago Sun-Times. Maisch examines how a strong biopharmaceutical research sector can help grow the state's economy.
Most Recent Posts
Over the weekend, The Washington Post ran an op-ed by Anthony Fauci, M.D., the director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, and one of the earliest pioneers in the field of HIV/AIDS research.
Over the last few weeks, Medicare has been front and center in the news. Elections and congressional votes have only reaffirmed that the program is highly regarded by seniors and the electorate.
A recent poll details this sentiment and shows voters will not react kindly to proposals that cut the Medicare program. The results are laid out in this Politico story.
There's a good piece over at Pharma Times On-line reminding us all of the work and giving by biopharmaceutical research companies to help the victims of the tsunami in Japan. The article notes that these critical contributions by medicine-makers are sometimes overlooked, with credit going to organizations and agencies providing direct services.
I was intrigued by a Reuters article I saw talking about General Electric and its renewed commitment to investing in research and development. The company clearly views increasing investment in R&D as the pathway to a secure future.
Today is World MS Day, a day intended to raise awareness of multiple sclerosis and to create a stronger network among the more than 2,000,000 patients around the world who live with this debilitating disease.
To help with the goal of raising awareness, PhRMA produced a brief, informative video featuring a multiple sclerosis expert, Sanofi's Associate Vice President and Head of the Multiple Sclerosis Distinct Project Unit Anita Burrell.
Today, the Joint Economic Committee is convening a hearing to discuss life-sciences jobs and innovation.
We hope that this hearing sheds light on the important economic role that our sector plays in America's economy, and we hope that it leads to recognition that the sector is worth promoting for future growth.
To that end, PhRMA's President and CEO John J. Castellani and Chairman of the Board and Sanofi CEO Christopher A. Viehbacher wrote an op-ed for The Hill about their hopes for the hearing.
Today, PhRMA released our new overview of the effect that medical advances have had on Americans, finding that new medicines have yielded significant progress in the battle against disease.
On Wednesday, Jerry Lewis announced that this year, he will retire as host of the Muscular Dystrophy Association's annual telethon - a position he has filled for 45 years.
I want to bring to your attention an interesting story about how the role of patients and patient support organizations are coming to play a bigger role in global health decision-making.
Hoosiers Work for Health, the Indiana chapter of We Work for Health held an event in Southern Indiana earlier this week calling attention to both the contribution that the biosciences make to Indiana's economy and the importance of creating an economic and investment environment in Indiana that promotes growth in the life sciences sector.
Healthcare providers know that no two patients are alike. And just as the saying goes that men are from Mars and women are from Venus, their bodies (and the ways in which they require care) are often worlds apart.
For example, heart attacks plague both genders, but the symptoms often vary. Women often metabolize medicines differently from men in ways that aren't explained simply by differences in body sizes. They are also more prone to diseases like multiple sclerosis, lupus, migraines, osteoporosis and fibromyalgia.
Down in Louisiana, where record flooding is becoming a real threat, Governor Bobby Jindal is recommending that residents who may have to evacuate their homes and communities remember to write down their prescription medicines before they leave their homes.
Battelle, the world's largest independent research organization, is out with a new report on the economic impact of the human genome project. The headline from the report is that the "$3.8 billion investment in the Human Genome Project drove $796 billion in economic impact creating 310,000 jobs and launching the genomic revolution."
The four main conclusions reached in the Battelle study are: